Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4127083 | Otolaryngology - Head and Neck Surgery | 2007 | 6 Pages |
Abstract
These results may serve as a base for future therapeutical applications in human beings, with modified versions of the L19(scFv)2 antibody, designed to selectively deliver bioactive molecules into malignant tumors.
Related Topics
Health Sciences
Medicine and Dentistry
Otorhinolaryngology and Facial Plastic Surgery
Authors
Manfred T. MD, Christina MD, Daniel MD, Dario PhD, Robert PhD, August PhD, Sandro J. MD, Stephen MD, Gerrhard W. MD,